Siglec-G Suppresses CD8<sup>+</sup> T Cells Responses through Metabolic Rewiring and Can be Targeted to Enhance Tumor Immunotherapy.
第一作者:
Shenhui,Yin
第一单位:
National Key Laboratory of Immunity & Inflammation, Naval Medical University/Second Military Medical University, Shanghai, 200433, China.
作者:
主题词
CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);动物(Animals);小鼠(Mice);免疫疗法(Immunotherapy);肿瘤(Neoplasms);人类(Humans);疾病模型, 动物(Disease Models, Animal);小鼠, 近交C57BL(Mice, Inbred C57BL);细胞系, 肿瘤(Cell Line, Tumor)
DOI
10.1002/advs.202403438
PMID
39373395
发布时间
2024-12-07
- 浏览0

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2024年11卷45期
e2403438页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文